comparemela.com

Latest Breaking News On - Astrazeneca stock - Page 1 : comparemela.com

IMFINZI (durvalumab) plus LYNPARZA (olaparib) and IMFINZI alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy

26.05.2023 - Positive high-level results from the DUO-E Phase III trial showed IMFINZI (durvalumab) in combination with platinum-based chemotherapy followed by either IMFINZI plus LYNPARZA (olaparib) or IMFINZI alone as maintenance therapy both demonstrated a .

Where next for AstraZeneca stock ahead of Q1 2022 earnings

Where next for the AstraZeneca share price ahead of Q4 earnings

Rio Preto usará doses da Pfizer para completar imunização de quem tomou AstraZeneca

Rio Preto usará doses da Pfizer para completar imunização de quem tomou AstraZeneca
diariodaregiao.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from diariodaregiao.com.br Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.